TrialHepatology (Baltimore, Md.)2019

Lusutrombopag for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Invasive Procedures (L-PLUS 2).

Markus Peck-Radosavljevic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.